ææ°ã® Pfizer Inc ã®æ ªåŒãã¥ãŒã¹ã決ç®ãã¢ããªã¹ãè©äŸ¡ãéèŠãªååã远跡ã§ããŸãã
7æ20æ¥ã®GSK plc (GSK) çµå€ã¯3.17%äžèœïŒå€åãã®èåŸã«ããäºå®
7æ6æ¥ã®AstraZeneca PLC (AZN) å€åãã¯3.79%äžèœïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
7æ2æ¥ã®Eli Lilly and Co (LLY) å€åãã¯3.06%äžæïŒäž»ãªæšé²èŠå ãæããã«ãããŸãã
7æ2æ¥ã®AstraZeneca PLC (AZN) å€åãã¯3.92%äžæïŒå®å šãªåæ
6æ24æ¥ã®Pfizer Inc (PFE) å€åãã¯3.16%äžèœïŒæè³å®¶ãç¥ã£ãŠããã¹ãæ å ±
6æ11æ¥ã®Gilead Sciences Inc (GILD) å€åãã¯3.48%äžæïŒå®å šãªåæ
6æ11æ¥ã®Amgen Inc (AMGN) å€åãã¯3.35%äžæïŒå€åãã®èåŸã«ããèŠå
6æ8æ¥ã®Bristol-Myers Squibb Co (BMY) çµå€ã¯3.00%äžèœïŒå€åãã®èåŸã«ããèŠå
6æ8æ¥ã®Novo Nordisk A/S (NVO) å€åãã¯3.46%äžèœïŒã©ã®ãããªã·ã°ãã«ã瀺ããŠããã®ãïŒ
6æ1æ¥ã®Novartis AG (NVS) å€åãã¯3.14%äžèœïŒå®å šãªåæ